SUBSCRIBE
SUBSCRIBE
News   Business

Leerink Swann and Company Appoints Joshua Schimmer, M.D. as Biotechnology Analyst

June 16, 2009 | 
1 min read
BOSTON--(BUSINESS WIRE)--Healthcare investment bank Leerink Swann announced that Joshua Schimmer, M.D. has joined the firm as Managing Director, Biotechnology Analyst. Dr. Schimmer will cover mid- and large-cap biotechnology companies for the Firm.
People
MORE ON THIS TOPIC
Social media illustration, business concept, web design
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
July 3, 2025
 · 
3 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
4DMT Thins Early-Stage Workforce, Focuses on Late-Stage Activities
July 3, 2025
 · 
152 min read
 · 
BioSpace Editorial Staff
Podcast
CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP
July 2, 2025
 · 
1 min read
 · 
Heather McKenzie
A contemporary artistic collage depicting a hand holding pills, passing them to another hand. The concept of medication and treatment.
Collaboration
Argenx Makes $1.5B+ Play for UNP’s Macrocyclic Peptides Aimed at ‘Undruggable’ Targets
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac